< Back to previous page
Researcher
Stefan Janssens
- Disciplines:Cardiac and vascular medicine
Affiliations
- Leuven Clinical Coordinating Centre (LCC) (Division)
Responsible
From1 Oct 2016 → Today - Cardiology (Division)
Responsible
From1 Jan 2012 → Today - Cardiology (Division)
Member
From1 Oct 1999 → Today
Projects
1 - 10 of 27
- BIOmarker based diagnostic TOOLkit to personalize pharmacological approaches in congestive heart failureFrom1 Oct 2023 → TodayFunding: Horizon Europe - Health
- Non-invasive assessment of functional, cellular and molecular mechanisms linking inflammation and cardiac remodeling after acute myocardial injury.From1 Jan 2023 → TodayFunding: FWO research project (including WEAVE projects)
- Cardiac regeneration by mRNA-triggered proliferation of cardiomyocytesFrom1 Sep 2022 → TodayFunding: Horizon Europe - Health
- Interventional X-ray system equipped with 3D rotational angiography for cardiovascular research in preclinical large animal models.From1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- A Deaf Heart Promotes Proliferation: Using iPSC-Based 3D Models to Study Mitogenic Cardiomyopathy in Alström Syndrome.From1 Oct 2021 → 30 Sep 2022Funding: BOF - postdoctoral mandates
- Studying the impact of modulated inflammation in cardiac ischemia reperfusion injury.From23 Sep 2021 → 1 Oct 2023Funding: FWO fellowships
- Cardiac remodeling after acute myocardial injury – understanding functional,cellular and molecular mechanisms by longitudinal in vivo imaging to reveal mechanisms for restoring endogenous cardioprotection.From1 Oct 2020 → TodayFunding: BOF - projects
- Risk prediction and modeling of cancer therapy related cardiotoxicityFrom1 Oct 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Computational biomechanics and bioengineering 3D printing to develop a personalized regenerative biological ventricular assist device to provide lasting functional support to damaged heartsFrom1 Jan 2020 → TodayFunding: H2020 - Food security, sustainable agriculture, marine and maritime research and the bio-economy
- Assessment and risk stratification of ageing-related target organ damage and adverse health outcomes in the general populationFrom1 May 2019 → 18 Nov 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 190
- Atrial Fibrillation and Dapagliflozin Efficacy in Patients With Preserved or Mildly Reduced Ejection Fraction(2022)
Authors: Stefan Janssens
Pages: 1705 - 1717 - Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction(2022)
Authors: Stefan Janssens
- Baseline Characteristics of Patients With HF With Mildly Reduced and Preserved Ejection Fraction DELIVER Trial(2022)
Authors: Stefan Janssens
Pages: 184 - 197 - The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial(2022)
Authors: Stefan Janssens
Pages: 568 - + - Empagliflozin in Heart Failure with a Preserved Ejection Fraction(2021)
Authors: Stefan Janssens
Pages: 1451 - 1461 - CLEC4E-Signalling in Myocardial Ischemia-Reperfusion Injury(2021)
Authors: Denise Veltman, Stefan Janssens, Peter Sinnaeve
- Rapid Exclusion of COVID Infection With the Artificial Intelligence Electrocardiogram(2021)
Authors: Stefan Janssens
Pages: 2081 - 2094 - Insights into therapeutic products, preclinical research models, and clinical trials in cardiac regenerative and reparative medicine: where are we now and the way ahead. Current opinion paper of the ESC Working Group on Cardiovascular Regenerative and Reparative Medicine(2021)
Authors: Stefan Janssens
Pages: 1428 - 1433 - Reparative cell therapy for the heart: critical internal appraisal of the field in response to recent controversies(2021)
Authors: Stefan Janssens
Pages: 2306 - 2309 - Microvascular Endothelium in Heart Failure(2021)
Authors: Sander Trenson, Stefan Janssens, Aernout Luttun
Patents
1 - 4 of 4